GARRETT SOILEAU: Open Payments
NPI 1992465488 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 55 payments from 14 companies in 2025. Trend: 2023 $1,295 · 2024 $944 · 2025 $1,032
Food & beverage: $923Education: $108
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $233 |
| ABBVIE INC. | 15 | $224 |
| GENZYME CORPORATION | 11 | $208 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| PFIZER INC. | 2 | $47 |
| ConvaTec Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $43 |
| Organon LLC | 2 | $28 |
| UCB, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, Rhapsido, CIBINQO, INNOVAMATRIX AC, TALTZ.
Industry payments across LA — which companies pay providers there.
